SIGACHI INDUSTRIES
|
SIGACHI INDUSTRIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -2.14 | 1.82 | 1.74 | 14.16 | 13.02 |
| CEPS(Rs) | -1.71 | 2.26 | 2.07 | 1.63 | 1.40 |
| DPS(Rs) | 0.10 | 0.10 | 0.10 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 13.65 | 15.72 | 11.32 | 87.29 | 74.09 |
| Tax Rate(%) | 5.58 | 23.68 | 17.92 | 20.09 | 22.41 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 11.25 | 20.48 | 19.21 | 19.44 | 21.19 |
| EBIT Margin(%) | -15.44 | 21.45 | 19.44 | 19.46 | 21.08 |
| Pre Tax Margin(%) | -18.35 | 18.91 | 17.49 | 18.04 | 20.62 |
| PAT Margin (%) | -17.33 | 14.43 | 14.35 | 14.41 | 16.00 |
| Cash Profit Margin (%) | -13.65 | 17.66 | 17.06 | 16.61 | 17.16 |
| Performance Ratios | |||||
| ROA(%) | -9.81 | 9.15 | 10.73 | 13.18 | 19.06 |
| ROE(%) | -14.75 | 14.49 | 17.90 | 17.55 | 24.87 |
| ROCE(%) | -10.72 | 16.42 | 17.90 | 20.53 | 27.93 |
| Asset Turnover(x) | 0.57 | 0.63 | 0.75 | 0.91 | 1.19 |
| Sales/Fixed Asset(x) | 1.15 | 1.31 | 1.77 | 2.83 | 4.18 |
| Working Capital/Sales(x) | 4.02 | 2.33 | 3.18 | 2.94 | 1.95 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.87 | 0.76 | 0.56 | 0.35 | 0.24 |
| Receivable days | 155.78 | 124.74 | 105.31 | 84.77 | 69.91 |
| Inventory Days | 64.11 | 61.67 | 53.67 | 46.55 | 37.66 |
| Payable days | 69.59 | 68.64 | 64.29 | 41.48 | 28.55 |
| Valuation Parameters | |||||
| PER(x) | - | 19.30 | 32.04 | 1.59 | 2.22 |
| PCE(x) | -9.96 | 15.57 | 26.91 | 13.80 | 20.70 |
| Price/Book(x) | 1.25 | 2.23 | 4.93 | 2.58 | 3.90 |
| Yield(%) | 0.59 | 0.28 | 0.18 | 0.44 | 0.35 |
| EV/Net Sales(x) | 1.59 | 2.84 | 4.77 | 2.32 | 3.41 |
| EV/Core EBITDA(x) | 12.24 | 11.52 | 21.53 | 10.71 | 15.35 |
| EV/EBIT(x) | -10.29 | 13.26 | 24.53 | 11.92 | 16.19 |
| EV/CE(x) | 1.15 | 1.93 | 3.42 | 2.26 | 3.25 |
| M Cap / Sales | 1.36 | 2.75 | 4.59 | 2.29 | 3.55 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -2.13 | 22.38 | 32.08 | 20.68 | 29.85 |
| Core EBITDA Growth(%) | -48.55 | 36.41 | 35.08 | 17.46 | 32.42 |
| EBIT Growth(%) | -170.46 | 35.07 | 31.94 | 11.37 | 32.81 |
| PAT Growth(%) | -217.52 | 23.04 | 31.54 | 8.74 | 32.31 |
| EPS Growth(%) | -217.53 | 4.49 | -87.70 | 8.74 | -66.94 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.26 | 0.20 | 0.34 | 0.15 | 0.15 |
| Current Ratio(x) | 1.44 | 2.13 | 1.67 | 2.38 | 3.50 |
| Quick Ratio(x) | 1.17 | 1.62 | 1.29 | 1.75 | 2.90 |
| Interest Cover(x) | -5.31 | 8.44 | 9.98 | 13.69 | 45.08 |
| Total Debt/Mcap(x) | 0.21 | 0.09 | 0.07 | 0.06 | 0.04 |
Compare Financial Ratios of peers of SIGACHI INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SIGACHI INDUSTRIES | ₹1,051.9 Cr | -3% | -11.8% | -30.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
SIGACHI INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SIGACHI INDUSTRIES | -3% |
-11.8% |
-30.1% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses
